San Carlos, CA · Founded 2018 · Privately Held (backing)
Developer of a drug delivery implantable system designed to treat patients with prostate cancer. Alessa Therapeutics is based in San Carlos, CA and was founded in 2018. It was valued at $49 million at its later-stage round in Apr 2025, the last priced event on record. It has raised $31.6 million across 3 recorded rounds; the latest was a $25.4 million early-stage round in Apr 2025.
PMV mark · valuation
$49.0M
Oct 2026
Priced at
its later-stage round
Apr 2025
Total raised
$31.6M
Last round
Early Stage VC
Apr 2025
Cap table — not yet on record
Alessa Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Alessa Therapeutics with a free account
·Watch Alessa Therapeutics: the Monday email on marks, rounds and moves
Where does Alessa Therapeutics's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Alessa Therapeutics's 3 recorded funding rounds.
